Infectious Disorders – Technologies for Molecular Testing – Labassure

Pregnancy

Infertility

Cancer

Cervical_Cancer

Pregnancy

Infertility

Children's Disorders

● Children’s Disorders

Infertility

Cancer

● Cervical Cancer

Infectious Disorders

● Infectious Disorders

Covid 19 Testing

● Covid 19 Testing

Tests

● Tests

Leverage the power molecular technologies for faster and more accurate and actionable diagnosis in case of infectious disorders

Advantages of molecular testing for viral infections

Rapid antigen tests are not always sensitive
Viral culture methods are too slow and have limited menu
Clinical presentation for several infections are at times, not specific
Easier sample transportation for molecular assays as compared to culture samples
Sensitivity of molecular assays estimated to be 3 to 5 times that of culture-based assays
Molecular tests identify approximately 50% more viral pathogens than culture

*Source: CAP Today, CDC 2011, Cochrane Review 2010

Quick Links

Maternal / Prenatal Screening

Pre-eclampsia Screening and Diagnosis

Prenatal Diagnosis

Non Invasive Prenatal Screening (NIPS)

LABASSURE is the diagnostics arm of Advanced Genomics Institute and Laboratory Medicine (AGILE). Labassure provides high quality diagnostic testing for various medical specialties such as pediatrics, gynecology, fetal medicine, obstetrics, infertility, oncology, ophthalmology, infectious disorders amongst others.

Our Links

Other Links

Contact Us

Designed & Developed by HeadStartt

LABASSURE is the diagnostics arm of Advanced GenomicsInstitute and Laboratory Medicine(AGILE). Labassure provides high quality diagnostictesting for various medical specialties suchas pediatrics, gynecology, fetal medicine, obstetrics,infertility, oncology, ophthalmology,infectious disorders amongst others

Our Links

Other Links

Contact Us

Designed & Developed By HeadStartt